Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 13-24 of 2,301
Behavioral study icon
RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing deuterated Psilocin Analog for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 85 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Cybin IRL Limited
Condition
Depression
Behavioral study icon
RecruitingNCT07284667

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

This study is comparing ACP-211 with placebo for people with depression or depression, Treatment-Resistant. Participants receive ACP-211 or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Depression
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06911112

NBI-1065845 for depression

This study is recruiting in the United States. It is testing NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06963021

NBI-1065845 for depression

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
RecruitingNCT05757791

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

This study is looking at whether Empagliflozin can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Depression
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

This study is recruiting in the United States. It is testing NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
Not Yet RecruitingNCT06748950

Ketogenic Metabolic Therapy in Schizophrenia, Bipolarity, Major Depressive Disorder: Deep Omic Profiling

This study is looking at whether LCHF Ketogenic Diet can help people with depression, psychosis, or bipolarity. Participants take part in LCHF Ketogenic Diet and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, Bipolarity, ...OtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity, ...
Drug study icon
Enrolling By InvitationNCT07161700

Safety study of SPT-300 (GlyphAllo) in depression

This study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 66 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
RecruitingNCT06830044

Milsaperidone for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing milsaperidone for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Vanda Pharmaceuticals
Condition
Depression
Behavioral study icon
RecruitingNCT03973268

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in people with Treatment-Resistant Major Depression

This study is looking at whether a digital support tool can help people with Depression or Major Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.